期刊文献+

From human genome epidemiology to systems epidemiology:current progress and future perspective

下载PDF
导出
摘要 The recent progress in human genome epidemiology(HuGE) is already having a profound impact on the practice of medicine and public health.First,the success of genome-wide association studies has greatly expanded the direction and content of epidemiological researches,including revealing new genetic mechanisms of complex diseases,identifying new targets for therapeutic interventions,and improving application in early screening of high-risk populations.At the same time,large-scale genomic studies make it possible to efficiently explore the gene-environment interactions,which will help better understand the biological pathways of complex diseases and identify individuals who may be more susceptible to diseases.Additionally,the emergence of systems epidemiology aims to integrate multi-omics together with epidemiological data to create a systems network that can comprehensively characterize the diverse range of factors contributing to disease development.These progress will help to apply HuGE findings into practice to improve the health of individuals and populations.
出处 《The Journal of Biomedical Research》 CAS CSCD 2020年第5期323-327,共5页 生物医学研究杂志(英文版)
基金 supported by the National Natural Science Foundation of China(Grant No.81521004 and No.81922061)。
  • 相关文献

参考文献2

二级参考文献54

  • 1Lohmueller KE, Pearce CL, Pike M, Lander ES, Hir-schhorn IN. Meta-analysis of genetic association studies supports a contribution of common variants to suscepti-bility to common disease. Nat Genet 2003; 33: 177-82.
  • 2Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med 2009; 360: 1759-68.
  • 3Klein C, Lohmann K, Ziegler A. The Promise and Limi-tations of Genome-wide Association Studies. lAMA 2012 Nov 8: 1-2. doi: 1O.100l/2012.jama.10823.[Epub ahead of print].
  • 4Wang M, Chu H, Zhang Z, Wei Q. Molecular epidemiol-ogy of DNA repair and head and neck cancer. 1 Biomed Res 2013 May. doi:l0.7555JJBR.27.20130034.[Epub ahead of print].
  • 5Chu H, Wang M, Zhang Z. Bladder Cancer Epidemiol-ogy and Genetic Susceptibility. 1 Biomed Res 2013 May. doi: 10.7555JJBR.27.20130026.[Epub ahead of print].
  • 6Zeggini E, Rayner W, Morris AP, Hattersley AT, Walker M, Hitman GA, et al. An evaluation of Hap Map sample size and tagging SNP performance in large-scale empiri-cal and simulated data sets. Nat Genet 2005; 37: 1320-2.
  • 7Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011; 43: 785-91.
  • 8Zhao J, Liu L, Zhang AQ, Chen Q, Fang W, Zeng L, Lu J. Effect of EMEI exon variant Ile350Thr on risk and early onset of breast cancer in southern Chinese women. J Biomed Res 2013 May. doi: 10.7555/JBR.27.20130013.[Epub ahead of print].
  • 9Liu L, Liu Y, Liu J, Zhai X, Wen J, Xie K, Shen H, Hu Z, Fan Z. Genetic variants in pseudogene E2F3Pl confer risk for HBV-related hepatocellular carcinoma in a Chi-nese population. J Biomed Res 2013 May. doi: 10.75551 JBR.27.20130019.[Epub ahead of print].
  • 10Cao S, Wang C, Huang X, Dai J, Hu L, Liu Y, Chen J, Ma H, Jin G, Hu Z, Xu L, Shen H. Prognostic Assess-ment of Apoptotic Gene Polymorphisms on Non-small Cell Lung Cancer in Chinese. J Biomed Res 2013 May. doi: 1O.7555/JBR.27.20130014.[Epub ahead of print].

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部